Amy Meadowcroft

Amy Meadowcroft currently serves as the Executive Director of Clinical Development at Stealth BioTherapeutics since September 2023. Prior to this role, Amy spent over 26 years at GlaxoSmithKline, where Amy held the position of Senior Director in Clinical Development, contributing expertise in various therapeutic areas including anemia of chronic kidney disease, women's health, urology, cardiovascular, and critical care. Additionally, Amy has experience in leadership roles for key R&D initiatives and served as a line manager throughout her tenure. Academic credentials include a Doctor of Pharmacy (PharmD) and a Bachelor of Applied Science (BASc) in Pharmacy, both from the University of North Carolina at Chapel Hill. Amy's early career included a post-doctoral fellowship in Drug Development at both the University of North Carolina and Duke University Health System, along with a pharmacy practice residency.